Crisaborole OverviewCrisaborole (trade name Eucrisa) is a nonsteroidal topical medication approved in the United States for the treatment of mild-to-moderate atopic dermatitis (eczema) in patients two years of age and older. It was approved by U.S. Food and Drug Administration on Dec 14, 2016. Contents 1 Mechanism of action 2 Chemistry 3 Drug development 4 See also 5 References Mechanism of action It is a phosphodiesterase-4 inhibitor, mainly act...
Read more Crisaborole Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Crisaborole
Recent Crisaborole Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Ointment: 2%
Other drugs which contain Crisaborole or a similar ingredient: (1 result)
- EUCRISA Crisaborole